ResMed to Report Third Quarter Fiscal 2022 Earnings on April 28, 2022
April 07 2022 - 4:05PM
ResMed to Report Third Quarter Fiscal 2022 Earnings on April 28,
2022
ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release
financial and operational results for the third quarter of fiscal
year 2022 on Thursday, April 28, 2022, after the New York Stock
Exchange closes. Following the release, ResMed management will host
a webcast to discuss these results. Other forward-looking and
material information may also be discussed during this webcast.
Earnings webcast details:
• |
Location: |
http://investor.resmed.com |
• |
Date: |
Thursday, April 28, 2022 |
• |
Time: |
1:30 p.m. PDT / 4:30 p.m.
EDT |
• |
International: |
London, Thursday, April 28, 9:30
p.m. BST |
|
|
Sydney, Friday, April 29, 6:30
a.m. AEST |
Please note that ResMed does not use outside phone lines to
access the earnings call.A replay of the earnings webcast will be
accessible on ResMed’s website and available approximately two
hours after the webcast. In addition, a phone replay will be
available approximately two hours after the webcast and will be
accessible from April 28 until May 12 at:
• |
U.S.: +1 877.660.6853 |
• |
International: +1
201.612.7415 |
• |
Conference ID: 13727876 |
|
|
About ResMedAt ResMed (NYSE: RMD, ASX: RMD) we
pioneer innovative solutions that treat and keep people out of the
hospital, empowering them to live healthier, higher-quality lives.
Our digital health technologies and cloud-connected medical devices
transform care for people with sleep apnea, COPD, and other chronic
diseases. Our comprehensive out-of-hospital software platforms
support the professionals and caregivers who help people stay
healthy in the home or care setting of their choice. By enabling
better care, we improve quality of life, reduce the impact of
chronic disease, and lower costs for consumers and healthcare
systems in more than 140 countries. To learn more, visit
ResMed.com and follow @ResMed.
|
|
For investors |
For media |
Amy Wakeham |
Jayme Rubenstein |
+1 858.836.5000 |
+1 858.836.6798 |
investorrelations@resmed.com |
news@resmed.com |
Resmed (LSE:0KW4)
Historical Stock Chart
From Dec 2024 to Jan 2025
Resmed (LSE:0KW4)
Historical Stock Chart
From Jan 2024 to Jan 2025